having opposing views is good. Encourages transparent opposing arguments which bring clarification. the Australian government assisted in publishing the below link to help investors understand biotech pharmaceutical investment. It is a much slower process due to a heavily regulated market and products that will only work commercially on a global level. your point about similar trials being done several years ago in any other sector would be a concern, but look at the typical timeline of drug development pathways on page 18 of the ASX ausgov doc below and you will see it’s right on schedule and completely normal to start with small tests over short periods then ramp up intensity over time years later. https://www.asx.com.au/documents/resources/AusBiotech-Guide-to-Life-Sciences-Investing-web-version.pdf
ACW Price at posting:
4.7¢ Sentiment: Buy Disclosure: Held
